About Us
We are an innovative marine biotechnology company pioneering disease prevention in aquaculture through customized autogenous vaccines, phage therapy, and advanced diagnostic services.
Our Commitment
Advancing Biotechnology Innovation
Aquatic Biologicals has built a new GMP facility for the production of autogenous vaccines for aquaculture. We are committed to advancing biotechnology innovation by providing high-quality, tailored solutions that meet the evolving needs of the aquaculture industry.
Our
Story
Get to Know Us
Founded in 2019, Aquatic Biologicals became the first official spin-off of the Hellenic Centre for Marine Research (HCMR), with a mission to advance fish health through innovative, science-driven solutions.
In 2021, IRIDA S.A., Greece’s largest fish feed company, joined as a strategic investor—strengthening our ability to scale research into real-world aquaculture applications.
In 2022, Aquatic Biologicals was proudly recognized as “Spin-off of the Year” in the Elevate Greece national innovation competition, honoring our impact in sustainable aquaculture and biotechnology.
Advantages of Our Solutions
Enhancing fish health
Experience the power of precision fish health solutions customized to prevent disease and meet the unique demands of the aquaculture industry.
Enhanced Vaccine Efficacy
Tailored Vaccine Formulations
Customized Production Processes
Autogenous Vaccine Production
Experience our expertise in autogenous vaccine production and discover how our solutions can enhance the health and performance of aquatic species in aquaculture.
Customized Formulation Development
Discover our innovative approach to developing customized vaccine formulations that address the specific health challenges faced by aquatic species in aquaculture.
Quality Assurance
Ensure the highest standards of quality with our comprehensive quality assurance protocols designed to uphold the safety and efficacy of our biotechnological products.
Regulatory Compliance
Navigate regulatory requirements with confidence, leveraging our expertise in ensuring compliance with industry regulations and standards.
Key Capabilities
Advanced Technology for Biotechnology
Discover how our cutting-edge biotechnology solutions deliver precise control over vaccine development, ensuring the health and welfare of aquatic species. Backed by state-of-the-art facilities and customized formulations, we are redefining the future of aquaculture health management.
State-of-the-Art Facilities
Experience the benefits of our state-of-the-art GMP facility, ensuring the highest standards of vaccine production and quality control to meet the specific needs of the aquaculture industry.
Tailored Formulation Expertise
Leverage our expertise in developing tailored vaccine formulations, addressing the unique health challenges faced by aquatic species in aquaculture to improve overall performance and welfare.
Research and Development
Stay ahead with our dedicated research and development initiatives focused on advancing biotechnology solutions for the aquaculture industry, driving continuous innovation and improvement.
Services
Vaccine development
We offer end-to-end vaccine development services, including pathogen isolation, characterization, and purification. In addition to formulating strain-specific vaccines and selecting suitable adjuvants, we support our clients by providing expert guidance in designing and implementing effective vaccination programs
Advanced diagnostics
Our advanced diagnostic services utilize cutting-edge -omics technologies to accurately identify and characterize fish pathogens. With specialized expertise in hard-to-study microorganisms, we provide reliable insights that support targeted disease management and vaccine development.
Phage therapy
Our team is pioneering the application of phage therapy in aquaculture, offering an innovative, antibiotic-free approach to bacterial disease control. Phages—viruses that specifically infect and kill bacteria— are at the core of our technology. We maintain a broad-spectrum library targeting Vibrio species and have the expertise to isolate, characterize, and propagate therapeutic phages tailored to specific pathogens.